Psyence Group Inc.
Psyence Group Inc.
CSE Index:
Currency:
Psyence Group Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. Psyence has built and operates one of the first federally licensed commercial psilocybin cultivation and production facilities. Psyence is pioneering the use of natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Psyence Group Inc. (PSYG)
SEDAR Information
Company Info
Address
2010, 200 Bay Street, PO Box 10
Toronto, ON M5J 2J1
CanadaPhone
1-416-477-1708Email
info@psyence.comWebsite
https://www.psyence.comListing date
Wednesday, January 27, 2021Transfer Agent
Odyssey Trust CompanyEmail
ir@psyence.comAuditor
MNP LLPCapitalization
Issued & Outstanding:
85,528,931Reserved for Issuance:
18,349,652Total equity shares, as if converted:
103,878,583Company Officers
Warwick Corden-Lloyd, CFO
Neil Maresky, CEO
News Releases
Bulletins
26/01/2021
2021-0130 – New Listing - Psyence Group Inc. (PSYG)
Le 26 janvier/January 2021
The common shares of Psyence Group Inc. previously listed as Cardinal Capital Partners Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
CSE Filings
Advertisement
Publicité
Upcoming Events
Capital Markets Comeback Tour
Wednesday, May 11, 2022 to Thursday, June 2, 2022
Tech Tuesdays
Series
Tech Tuesdays
Series
